Status:
UNKNOWN
Multicenter Observational Study of Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Rare Driver Gene Mutation
Lead Sponsor:
Shanghai Pulmonary Hospital, Shanghai, China
Conditions:
Chinese
Non-Small Cell Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Title: Multicenter observational study for clinicopathological characteristics and clinical efficacy of Chinese Non-Small Cell Lung Cancer (NSCLC) patients With Rare Driver Gene Mutation. Purpose: To...
Detailed Description
Inclusion criteria: 1. Female or male, 18 years of age or older； 2. Histologically or cytologically proven diagnosis of NSCLC； 3. Able to get tumor tissue gene testing results by lung cancer Polymera...
Eligibility Criteria
Inclusion
- Female or male, 18 years of age or older；
- Histologically or cytologically proven diagnosis of NSCLC；
- Able to get tumor tissue gene testing results by lung cancer PCR panel kit carried out in hospital；
- Signed and dated informed consent。
Exclusion
- Combine with other tumor type
- The investigator judges the situation that may affect the clinical search process and results
Key Trial Info
Start Date :
October 25 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 20 2024
Estimated Enrollment :
50000 Patients enrolled
Trial Details
Trial ID
NCT04137718
Start Date
October 25 2019
End Date
October 20 2024
Last Update
December 27 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Pulmonary Hospital
Shanghai, Shanghai Municipality, China, 200000